Actuate Therapeutics, Inc. (ACTU)
NASDAQ: ACTU · Real-Time Price · USD
2.280
+0.070 (3.17%)
Mar 25, 2026, 2:37 PM EDT - Market open
ACTU's stock price has decreased by -70% in the past year and price targets may not have had time to catch up.

Actuate Therapeutics Analyst Ratings

Total Analysts
2
Consensus Rating
Strong Buy
Price Target
$20.00
Upside
+777.19%

Ratings History

AnalystFirmRatingRatingActionPrice TargetUpsideDate
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$20
Strong BuyReiterates$20+777.19%Nov 19, 2025
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$20
Strong BuyReiterates$20+777.19%Sep 23, 2025
B. Riley Securities
B. Riley Securities
Strong Buy
Initiates
$20
Strong BuyInitiates$20+777.19%Aug 26, 2025
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$20
Strong BuyReiterates$20+777.19%Aug 18, 2025
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Initiates
$20
Strong BuyInitiates$20+777.19%Mar 17, 2025